Saturday, October 31, 2026

Peloton Stock Was Up By 11.42% Today

ViaNews Editorial Team

December 22, 2020

Peloton Stock Was Up By 11.42%  Today

The Nasdaq Stock Market ended the session with Peloton jumping 11.42% to $160.88 on Tuesday, after five successive sessions in a row of gains. The Nasdaq Stock Market jumped 0.39% to $12,792.10, after two successive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Peloton today's close was $160.88, 3.33% under its 52-week high of $166.23.

News about Peloton today

Stocks making the biggest moves in the premarket: Peloton, sportsman's warehouse, fubotv & more. According to today's article on CNBC, "Peloton (PTON) - Peloton is acquiring rival fitness equipment maker Precor for $420 million, in a deal that will give it more market share as well as increased manufacturing capacity. ", "The acquisition prompted KeyBanc Capital Markets to raise its price target on Peloton from $160 to a Street-high $185, saying the deal was "highly synergistic" and supportive of long-term growth. "

Peloton buying Precor makes for a smoother ride. According to today's article on Bloomberg Quint, "The first helps to solve Peloton's supply difficulties now, while the latter will give it an edge in the post-Covid economy whenconsumers are no longer forced to exercise athome and avoid travel.", "Precor might just be the workhorse thatelevates Peloton fromfad spin brand to fitness juggernaut."

Peloton spins to 'born in the U.S.a.'. According to today's article on The Wall Street Journal, "Home-fitness giant Peloton wants to be homemade. ", "The purchase of Precor will add 625,000 square feet of U.S. manufacturing capacity to Peloton's armory, which had been limited to third-party manufacturers and facilities based in Taiwan. "

The company's growth estimates for the ongoing quarter and the next is 140% and 115%, respectively.

Peloton's Revenue

Year-on-year quarterly revenue growth grew by 232.4%, now sitting on 2.36B for the twelve trailing months.

Peloton's Stock Yearly Top and Bottom Value

Peloton's stock is valued at $160.88 at 16:14 EST, under its 52-week high of $166.23 and way above its 52-week low of $17.70.

Peloton's Moving Average

Peloton's value is way above its 50-day moving average of $115.23 and way above its 200-day moving average of $88.73.

Previous days news about Peloton

Peloton makes biggest purchase with $420 million Precor deal. According to Bloomberg Quint on Mon Dec 21, "No one would wish a global pandemic on anybody, but it's been a tailwind for our business," Peloton President William Lynch said. ", "He will also be general manager of the new Peloton Commercial business, reporting to Lynch, the company said."

Peloton to buy fitness equipment maker Precor in $420 million deal. According to MarketWatch on Mon Dec 21, "The company's gross margins were affected as Peloton spent to overcome the logistics difficulties.", "Peloton has been manufacturing equipment in Taiwan, affecting its ability to deliver equipment to American consumers."

Peloton will spend $420 million to acquire Precor, known for making fitness equipment found in hotels, health clubs, and university gyms. According to Business Insider on Mon Dec 21, "Peloton will acquire Precor, a hotel and university fitness equipment maker, for $420 million.", "Echelon Fitness, which describes itself as the "most formidable competitor of Peloton," sells bikes cheaper than Peloton's nearly $2,000 model, and reported a sales increase of 700% year-over-year in September."

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com